CCR9 and non-small cell lung carcinoma: In NSCLC, CCR9/CCL25 drives proliferation, metastasis, and immune evasion through upregulation of VEGF, MMPs, and anti-apoptotic proteins, with its overexpression correlating with advanced disease and poor prognosis.